Beacon Bio

United States Founded: 2021 • Age: 5 yrs
A regenerative tissue graft for eardrum repair is developed.

About Beacon Bio

Beacon Bio is a Healthcare company based in United States founded in 2021 by Jennifer Lewis, Elliott Kozin, and Aaron Remenschneider. A regenerative tissue graft for eardrum repair is developed. Its focus areas include Life Sciences, ENT Disorders, Medical Devices and Therapeutic Devices. Its competitors include Advanced Bionics, Sofregen and Cerapedics; 3 of its 3 listed competitors have raised funding.

Company details

Beacon Bio was founded in 2021 in the United States within the biotechnology sector. Focus is placed on regenerative medicine, where a biodegradable device called PhonoGraft is created to address chronic eardrum perforations. The graft features a structure that mimics the natural eardrum and uses materials designed to integrate and remodel into functional tissue over time. Operations involve research and development for ear repair solutions.

  • Headquarters United States
  • Founders Jennifer Lewis, Elliott Kozin, Aaron Remenschneider
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website beacon-bio.com

People of Beacon Bio

3 people are tracked at Beacon Bio (3 in leadership).

NameRoleGroup
Jennifer Lewis
Co-FounderLeadership
Elliott Kozin
Co-FounderLeadership
Aaron Remenschneider
Co-FounderLeadership
Premium access

Complete people profiles for Beacon Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of Beacon Bio

Beacon Bio has 3 listed competitors in our database, 3 of them funded. They include Advanced Bionics, Sofregen and Cerapedics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
advancedbionics.com1993Valencia, United States$78.06M687
Provider of advanced cochlear implants and hearing technology for powerful connections
sofregen.com2014Medford, United States$17.8M8
Silk-derived biomaterials are developed for soft tissue repair in surgery.
cerapedics.com2006Westminster, United States$88.46M3
Osteobiologic products are developed using synthetic peptide technology.
Premium access

Detailed competitors of Beacon Bio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Organ-on-Chip & Regenerative Solutions

3 companies that operate in the same segment as Beacon Bio (Organ-on-Chip & Regenerative Solutions) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Human tissue-based products are developed for vascular disease applications.
2004Morrisville, United StatesUSD 424.76 MUSD 2.04 M220
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
1985Marietta, Georgia, United StatesUSD 418.63 M837
Synthetic adhesives for bone and dental repair are developed.
2014Lowell, Massachusetts, United StatesUSD 24.42 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Beacon Bio

Beacon Bio was founded in 2021.

Beacon Bio is headquartered in United States.

Beacon Bio was founded in 2021 in the United States within the biotechnology sector. Focus is placed on regenerative medicine, where a biodegradable device called PhonoGraft is created to address chronic eardrum perforations. The graft features a structure that mimics the natural eardrum and uses materials designed to integrate and remodel into functional tissue over time. Operations involve research and development for ear repair solutions.

Beacon Bio's top competitors include Advanced Bionics, Cerapedics and Sofregen.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available